The diagnostics, research tools, and medical device markets are large, vibrant, high-technology sectors. Industry participants range from diversified global manufacturers to emerging, innovative niche product suppliers.
BGL’s Diagnostics, Research Tools & Medical Devices Investment Banking team has decades of experience advising companies across the diagnostics and device landscape. Our team is well-studied and up-to-date on the latest medical device industry trends. With this in-depth knowledge and background, we have provided capital formation, technology strategy, corporate ventures, and medical device M&A strategy for a wide range of diagnostics, research tools, and device companies.
We maintain active relationships with global industry participants and capital providers, which furthers our deep understanding of diagnostics, research tools, and medical device industry trends. We closely follow regulatory and reimbursement trends, which positions the BGL team as a trusted and prominent advisor for a variety of diagnostics, research tools, and medical device companies.
Our sector involvement enables us to not only provide unique access to capital providers, but also identify and execute on strategic opportunities for our investment banking clients.
Areas of Expertise
- Instruments & devices
- Point-of-care diagnostics
- Controls, reagents, & consumables
- Lab equipment & supplies
- Lab automation and sample prep
- Drug discovery tools
Featured Transaction: BGL Advises in the Sale of Preclinical ADME-Toxicology Services Provider Cyprotex PLC
By providing support through every stage of the transaction process, BGL’s team delivered a successful outcome for Evotec, which, with this acquisition, will strengthen its high-end drug discovery platform and capabilities. BGL served as the exclusive financial advisor to Cyprotex; learn more about this medical device M&A transaction.
- Pharmaceutical services & outsourcing
- Drug delivery
Featured Transaction: BGL Completes the Sale of Orthoplastics to MedPlast
Engineered by BGL professionals who are experts in a wide range of medical M&A engagements, this acquisition expands MedPlast’s ability to serve the orthopedic device OEMs, while significantly growing its customer base and global strategic footprint. BGL’s Healthcare & Life Science Investment team and Industrials team jointly initiated the transaction and served as the exclusive financial advisor to Orthoplastics; learn more about this medical device M&A transaction.
- Sterilization/infection control
- Surgical instruments
- Women’s health
- Wound care
Contact our Diagnostics, Research Tools & Medical Devices Investment Banking Team
With more than 20 years of experience in all aspects of medical device M&A and partnering agreements, Christoph D. Brandenberger leads BGL’s Diagnostics, Research Tools & Medical Devices Investment Banking team. For more information on how our team can assist with medical device M&A, the valuation of diagnostic companies, or other aspects of medical device investment banking, please reach out via our contact form.